Note revised IND for Stage 2 of 002 is seperate discussion to DMOAD and therefore likely timing.
I'm no concerned about FDA feedback on 008 results rather see it as blue sky to potential mega blockbuster durable pain and function results from 002. Treating doctors and patients will simply frontrun the FDA, EMA and TGA. But NOT giving up on China either.
Where we at?, page-280
-
- There are more pages in this discussion • 427 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.010(4.08%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 26.0¢ | 24.5¢ | $65.17K | 254.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 64000 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 14407 | 2 |
View Market Depth
| Last trade - 16.10pm 01/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |